Optic disc stereo-photography: Does it have a role in the OCT era?July 15th 2018
Stereoscopic photographs are a useful tool in the detection of glaucoma, however, the difficulty in obtaining them has seen them underused in favour of optical coherence tomography (OCT). A new device is attempting to redress this balance, enabling stereo-photography to be used alongside OCT for optimal practice.
The importance of pattern electroretinography in detecting early-stage glaucomaJune 12th 2018
As an objective measure of the function of retinal ganglion cells, pattern electroretinography (PERG) testing reveals subclinical optic nerve changes that may be critical for deciding when to start therapy to avoid vision loss from glaucoma progression.
A paradigm for the treatment of ocular hypertension in glaucoma suspectsApril 16th 2018
The combined clinical use of pattern electroretinography for the detection of early glaucoma indicators and selective laser trabeculoplasty for intervention may help realise the potential of early detection and treatment.
Optical coherence tomography angiography (OCTA) is a new imaging technique that has the potential to move rapidly into routine clinical practice. OCTA comprises different OCT-based technologies, which enable the non-invasive assessment of retinal perfusion, based on red blood cell movement in the optic nerve head, the peripapillary and the macular retina.
Opportunities and challenges in the world of ophthalmology in 2018December 1st 2017
As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.
Applying micropulse transscleral cyclophotocoagulation for early-stage glaucomaNovember 1st 2017
Micropulse transscleral cyclophotocoagulation utilises a different delivery modality than its predecessor, continuous-wave laser cycloablation, to produce a biological reaction without the lethal effects caused by thermal buildup.
Exploring safety, efficacy of high-intensity focused ultrasound in glaucomaAugust 9th 2017
High-intensity focused ultrasound cyclocoagulation is safe and effective in most refractory glaucomatous eyes. Complete success was achieved in 80% (24/30) of treated eyes that had undergone the maximum of three procedures.
Glaucoma monitoring implant receives CE markJune 20th 2017
An implantable glaucoma sensor has received CE mark approval for marketing in the European Union. The sensor (Eyemate, Implandata Ophthalmic Products) can provide frequent IOP readings, informing patients and their physicians about how the pressure changes by time of day and from one day to another.
New technology predicts conversion to POAGAugust 10th 2016
Clinicians can predict which patients with ocular hypertension are most likely to develop primary open-angle glaucoma (POAG) using short-wave automated perimetry, scanning laser polimetry, and confocal laser ophthalmoscopy, as well as the patient’s age, researchers said.
Why you need to beware of potential mimickers of paediatric glaucomaApril 1st 2016
Although the diagnosis of primary congenital or early developmental glaucoma is often straightforward, similar phenotypic features can occur in other paediatric conditions, which are consequently sometimes mistaken for early childhood glaucoma. Ophthalmologists who care for children with glaucoma must keep such potential mimics in mind.
Novel device reliably measures iridocorneal anglesFebruary 17th 2016
Scheimpflug photography using a novel device (Sirius, Costruzione Strumenti Oftalmici) provides consistent measurements of the iridocorneal angle at different meridians in healthy eyes and could be used to detect occludable angles.
Why 'the more the merrier' doesn't apply to glaucoma monitoringDecember 1st 2015
Though ocular hypertension may be the only modifiable risk factor for glaucoma, the second-leading cause of sight loss in the United Kingdom, monitoring for ocular hypertension more than twice a year is not efficient, researchers said.
Combination glaucoma drop moves toward approvalOctober 30th 2014
A preservative-free IOP-lowering eye drop that is a combination of tafluprost and timolol (Taptiqom, Santen) is seeking national licences in European countries after a positive decentralized procedure and a final assessment report from reference member state Germany, the Federal Institute for Drugs and Medical Devices of Germany, and agreement by concerned member states that the fixed-dose product is approvable.